Chemomab Therapeutics (CMMB) Treasury Shares (2022 - 2025)

Name: Chemomab Therapeutics (CMMB) Treasury Shares (2022 - 2025) | Business Quant
Creator: Business Quant

Chemomab Therapeutics posted quarterly Treasury Shares of $10.1 million for Q4 2025, down 13.48% on a QoQ basis from $11.6 million in Q1 2023.

Chemomab Therapeutics (CMMB) has 2 years of Treasury Shares data on file, last reported at $1.2 million in Q1 2023.

For the quarter ending Q4 2025, Treasury Shares changed N/A year-over-year to $10.1 million; the trailing twelve-month figure through Dec 2025 stood at $10.1 million (changed N/A YoY), and the FY2025 full-year result was $10.1 million, changed N/A from the prior year.
Treasury Shares for Q1 2023 stood at $1.2 million, roughly flat from $1.2 million in the prior quarter.
Across five years, Treasury Shares topped out at $11.6 million in Q1 2023 and bottomed at -$11.6 million in Q4 2022.
The 3-year median for Treasury Shares is $10.1 million (2025), against an average of $3.4 million.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Quantum Biopharma	961,148.99 Bn	961,148.98 Bn	-	-
2	Alterity Therapeutics	744,933.29 Bn	744,933.26 Bn	-	-
3	Legend Biotech	2,540.00 Bn	2,539.71 Bn	242.10 Mn	-
4	Nanobiotix	2,199.85 Bn	2,199.78 Bn	-	265,401.92
5	Akari Therapeutics	1,635.88 Bn	1,635.88 Bn	-	-
6	Vertex Pharmaceuticals	111.32 Bn	104.07 Bn	2.59 Bn	700,000.00
7	Evaxion A	62.56 Bn	62.54 Bn	-	-
8	Regeneron Pharmaceuticals	62.55 Bn	53.79 Bn	3.31 Bn	34.70 Mn
9	Alnylam Pharmaceuticals	39.57 Bn	36.56 Bn	959.66 Mn	-
10	Chemomab Therapeutics	959.23 Mn	948.86 Mn	-	10.07 Mn

Download Data 🔒